QYResearch is a leading market research publisher which pursuits high product quality with the belief that quality is the soul of business and consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience.

Los Angeles, CA -- (SBWire) -- 12/12/2018 --This report studies the global market size of Radiopharmaceutical in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Radiopharmaceutical in these regions.

This research report categorizes the global Radiopharmaceutical market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.

In the next few years, Radiopharmaceuticals industry will maintain increasing at a relatively high growth rate. Investors are still optimistic about this area; the future will still have more new investment enter the field.

The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The revenue proportion of Diagnostic Radioisotopes in 2016 is about 77%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.

Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 60%.

In 2017, the global Radiopharmaceutical market size was 4940 million US$ and is forecast to 9520 million US in 2025, growing at a CAGR of 8.6% from 2018. The objectives of this study are to define, segment, and project the size of the Radiopharmaceutical market based on company, product type, application and key regions.

Request Sample PDF Report Copy@ https://www.qyresearch.com/sample-form/form/738935/global-radiopharmaceutical-market

The various contributors involved in the value chain of Radiopharmaceutical include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Radiopharmaceutical include

Bracco Imaging

Bayer

Mallinckrodt

Nordion

Triad Isotopes

Lantheus

IBA Group

GE Healthcare

China Isotope & Radiation

Jubilant Pharma

Eli Lilly

Advanced Accelerator Applications

SIEMENS

Dongcheng

Navidea

Market Size Split by Type

Actinium-225

Lutetium-177

Radium-223

Holmium-166

Other

Market Size Split by Application

Oncology

Cardiology

Other

Buy Full market Report Now, Report delivery time within 24 hours @ https://www.qyresearch.com/settlement/pre/42aba5d618d263c86111b29b7aaab6d7,0,1,Global%20Radiopharmaceutical%20Market%20Insights%252C%20Forecast%20to%202025

About QYResearch
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.